NeuroSigma Announces Debut of Its Monarch eTNS System in Canada LOS ANGELES, June 21, 2013 /PRNewswire/ -- NeuroSigma, Inc . , a Los Angeles based medical device company, today announced that its Monarch ™ eTNS™ System for the adjunctive treatment of epilepsy and ...
June 21, 2013 - PR Newswire via Yahoo! Finance
Daniel in MarketWatch (press release) Multiple studies have demonstrated that Azilect(R) may play an important role in the treatment of Parkinson's disease, both as monotherapy and as adjunctive therapy,said Daniel Kremens, MD, assistant professor of neurology and co-director of...
Al Capone in Wired News RetCam right now is a very useful adjunctive tool,Capone said, "but it is not yet a technology that can completely supplant an onsite exam by an experienced ophthalmologist."